ARCHIVES

Survey Commissioned By Cancer Control Program Finds Important RMP Effort Being Phased Out

This article is from The Cancer Letter archive.

Vol. 01 No. 24 | July 19, 1974

Download PDF Visit The Full Archive

Related Articles

NCI reassigns project officer John Gohagan.

April 16, 2004

PDX Shows 27% Response In T-Cell Lymphoma In Study

December 26, 2008

Funding opportunities listed.

April 30, 2004

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Drug Development Effort Criticized

April 18, 1975

President Proposes $1 Billion Increase For NIH In FY2011; Cancer A High Priority

February 5, 2010